Vinpocetine Exerts Neuroprotective Effects via Downregulating α-Syn in Rotenone-induced Cellular Models of Parkinson's Disease

被引:0
作者
Ji, Meng [1 ]
Xu, Ji-Hua [1 ]
Mi, He-Yin [1 ]
Jiang, Peng [1 ]
Li, Yue [1 ]
机构
[1] Capital Med Univ, Beijing Chao Yang Hosp, Dept Neurol, Beijing 100020, Peoples R China
关键词
Parkinson's disease; Vinpocetine; alpha-synuclein; Cytotoxicity; Dopaminergic; Polyvinylidene fluoride; ISCHEMIC-STROKE;
D O I
10.2174/0115701808274204231012111936
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Objective: Vinpocetine (Vinp), a derivative of alkaloid vincristine with anti-inflammatory and antioxidant effects, has been shown to have neuroprotective effects in Parkinson's disease (PD). Its role and mechanisms, however, are not fully understood. Therefore, the aim of this study was to investigate the effects and possible mechanisms of Vinp on PD cells.Methods: SH-SY5Y cells were treated with Vinp and then with rotenone to induce a cellular model of PD. The proliferation level and apoptosis rate of SH-SY5Y cells after different treatments were detected by MTT and flow cytometry assays, respectively. Western blot was used to determine the relative protein expression of alpha-Synuclein (alpha-Syn) in differently treated cells. Additionally, commercial kits and ELISA were used to determine oxidative stress-related indicators (superoxide dismutase (SOD), malondialdehyde (MDA), and reactive oxygen species (ROS)) and inflammatory factors (tumor necrosis factor alpha [TNF-alpha], interleukin-5 (IL-5), and interleukin-1 beta (IL-1 beta)) in SH-SY5Y cells after different treatments, respectively.Results: Vinp at different concentrations (5, 10, and 50 mu M) had no significant effect on the proliferation and apoptosis of SH-SY5Y cells. For rotenone-induced SH-SY5Y cells, Vinp pretreatment could significantly reduce alpha-Syn expression, increased cell viability and decreased apoptosis, oxidative stress (downregulation of ROS and MDA levels and upregulation of SOD activity) and inflammation (increased levels of TNF-alpha, IL-5, and IL-1 beta). In contrast, overexpression of alpha-Syn in SH-SY5Y cells with Vinp pretreatment and rotenone induction partially reversed the aforementioned protective effects of Vinp, causing a decrease in proliferation, an increase in apoptosis rate, inflammation, and oxidative stress.Conclusion: Vinp exerted neuroprotective effects by downregulating alpha-Syn to promote proliferation, inhibit apoptosis, and inhibit oxidative stress and inflammation in rotenone-induced SH-SY5Y cells.
引用
收藏
页码:3060 / 3067
页数:8
相关论文
共 39 条
  • [21] The central role of the NLRP3 inflammasome pathway in the pathogenesis of age-related diseases in the eye and the brain
    Maran, Jack J.
    Adesina, Moradeke M.
    Green, Colin R.
    Kwakowsky, Andrea
    Mugisho, Odunayo O.
    [J]. AGEING RESEARCH REVIEWS, 2023, 88
  • [22] Impact of SAfinamide on Depressive Symptoms in Parkinson's Disease Patients (SADness-PD Study): A Multicenter Retrospective Study
    Pena, Esteban
    Borrue, Carmen
    Mata, Marina
    Carlos Martinez-Castrillo, Juan
    Alonso-Canovas, Araceli
    Luis Chico, Juan
    Lopez-Manzanares, Lydia
    Llanero, Marcos
    Herreros-Rodriguez, Jaime
    Esquivel, Alberto
    Maycas-Cepeda, Teresa
    Ruiz-Huete, Cristina
    [J]. BRAIN SCIENCES, 2021, 11 (02) : 1 - 11
  • [23] Parkinson's Disease: Risk Factor Modification and Prevention
    Rajan, Suraj
    Kaas, Bonnie
    [J]. SEMINARS IN NEUROLOGY, 2022, 42 (05) : 626 - 638
  • [24] Early use of donepezil against psychosis and cognitive decline in Parkinson's disease: a randomised controlled trial for 2 years
    Sawada, Hideyuki
    Oeda, Tomoko
    Kohsaka, Masayuki
    Umemura, Atsushi
    Tomita, Satoshi
    Park, Kwiyoung
    Mizoguchi, Kouichi
    Matsuo, Hidenori
    Hasegawa, Kazuko
    Fujimura, Harutoshi
    Sugiyama, Hiroshi
    Nakamura, Michikazu
    Kikuchi, Seishi
    Yamamoto, Kenji
    Fukuda, Toshiaki
    Ito, Suminobu
    Goto, Masashi
    Kiyohara, Kosuke
    Kawamura, Takashi
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (12) : 1332 - 1340
  • [25] Continuous Drug Delivery in Parkinson's Disease
    Senek, Marina
    Nyholm, Dag
    [J]. CNS DRUGS, 2014, 28 (01) : 19 - 27
  • [26] VINPOCETINE ATTENUATES MPTP-INDUCED MOTOR DEFICIT AND BIOCHEMICAL ABNORMALITIES IN WISTAR RATS
    Sharma, S.
    Deshmukh, R.
    [J]. NEUROSCIENCE, 2015, 286 : 393 - 403
  • [27] A secret that underlies Parkinson's disease: The damaging cycle
    Sun, Feiyi
    Deng, Yulin
    Han, Xiaowei
    Liu, Qingqing
    Zhang, Peng
    Manzoor, Robina
    Ma, Hong
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2019, 129
  • [28] Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients:: a PET study
    Szilágyi, G
    Nagy, Z
    Balkay, L
    Boros, I
    Emri, M
    Lehel, S
    Márián, T
    Molnár, T
    Szakáll, S
    Trón, L
    Bereczki, D
    Csiba, L
    Fekete, I
    Kerényi, L
    Galuska, L
    Varga, J
    Bönöczk, P
    Vas, A
    Gulyás, B
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 229 : 275 - 284
  • [29] Rotenone-Induced Model of Parkinson's Disease: Beyond Mitochondrial Complex I Inhibition
    Teresa Ibarra-Gutierrez, Maria
    Serrano-Garcia, Norma
    Orozco-Ibarra, Marisol
    [J]. MOLECULAR NEUROBIOLOGY, 2023, 60 (4) : 1929 - 1948
  • [30] Pathological Gambling in Parkinson Disease Is Reduced by Amantadine
    Thomas, Astrid
    Bonanni, Laura
    Gambi, Francesco
    Di Iorio, Angelo
    Onofrj, Marco
    [J]. ANNALS OF NEUROLOGY, 2010, 68 (03) : 400 - 404